Company research
ACTAVIA LIFE SCIENCES, INC.
CIK 1582249Updated Nov 16, 2026
SecurityRASP · OTC · equity
Name history
Rasna Therapeutics Inc. · through Aug 14, 2023Active With Me Inc. · through Sep 26, 2016
RASP price & chart
Loading TradingView…
OTC:RASP on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2023 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 95,657Source | 85,276Source | 44,577Source | 32,944Source |
| Property, Plant and Equipment, NetUSD | — | — | — | 314Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | — | — | 14,241Source |
| Assets, CurrentUSD | — | — | 44,577Source | 32,630Source |
| Prepaid Expense and Other Assets, CurrentUSD | 20,671Source | 45,913Source | 33,729Source | 17,641Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 2,051,566Source | 1,773,873Source | — | 2,707,632Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 771,811Source | 179,979Source | 68,909Source | 68,909Source |
| Additional Paid in CapitalUSD | 25,935,882Source | 22,352,491Source | — | — |
| Retained Earnings (Accumulated Deficit)USD | -28,663,602Source | -24,221,067Source | -23,534,479Source | -22,658,481Source |
| Stockholders' Equity Attributable to ParentUSD | -1,955,909Source | -1,688,597Source | -2,753,812Source | -2,674,688Source |
| Additional Paid in Capital, Common StockUSD | — | — | 20,711,758Source | 19,914,884Source |
| Liabilities and EquityUSD | 95,657Source | 85,276Source | 44,577Source | 32,944Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 2,051,566Source | 1,681,906Source | 2,798,389Source | — |
| Accounts Payable, CurrentUSD | 959,659Source | — | — | 952,151Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 498,557Source | — | — | 683,637Source |
cash flow · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -875,998Source | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 3,858,793Source | — | 42,673Source | 134,632Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | -3,034Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -8,516Source | -312,663Source | -293,393Source | -251,327Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 44,139Source | 341,178Source | 290,000Source | 215,500Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 74,986Source | 39,363Source | 10,848Source | — |
| Additional Financial Items | ||||
| DepreciationUSD | — | — | 314Source | 1,635Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | 8,851Source | 113,317Source | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | 590Source |
| Gain (Loss) on Sale of Assets and Asset Impairment ChargesUSD | — | — | — | 120,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | 375,000Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | 150,000Source | — | — |
| General and Administrative ExpenseUSD | 287,374Source | 300,070Source | 247,814Source | 463,579Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | 2,149,369Source |
| Goodwill, Impairment LossUSD | — | — | — | 2,722,985Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | 2,149,369Source |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | — | — | 2,149,369Source |
| Income Tax Expense (Benefit)USD | — | — | — | -3,034Source |
| Net Income (Loss) Attributable to ParentUSD | -4,442,535Source | -686,588Source | -875,998Source | -5,346,672Source |
| Operating ExpensesUSD | 4,238,414Source | -141,088Source | 247,814Source | 5,428,858Source |
| Other Nonoperating Income (Expense)USD | -204,121Source | -827,676Source | — | 79,152Source |
| Other Operating Income (Expense), NetUSD | — | — | -628,184Source | — |
| Unrealized Gain (Loss) on DerivativesUSD | 8,851Source | 113,317Source | — | — |
income statement · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -4,238,414Source | 141,088Source | -247,814Source | -5,428,858Source |
| Other Nonoperating Income (Expense)USD | -204,121Source | -827,676Source | — | 79,152Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | -5,349,706Source |
| Income Tax Expense (Benefit)USD | — | — | — | -3,034Source |
| Net Income (Loss) Attributable to ParentUSD | -4,442,535Source | -686,588Source | -875,998Source | -5,346,672Source |
| Earnings Per Share, BasicUSD per share | -0.01Source | -0.01Source | -0.01Source | — |
| Earnings Per Share, DilutedUSD per share | -0.01Source | -0.01Source | -0.01Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 578,016,591Source | 111,425,950Source | 68,908,003Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 578,016,591Source | — | — | — |
| Additional Financial Items | ||||
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | 590Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | 375,000Source | — | — |
| General and Administrative ExpenseUSD | 287,374Source | 300,070Source | 247,814Source | 463,579Source |
| Goodwill, Impairment LossUSD | — | — | — | 2,722,985Source |
| Income (Loss) Attributable to Parent, before TaxUSD | -4,442,532Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -4,442,532Source | -686,588Source | -875,998Source | -5,349,706Source |
| Interest ExpenseUSD | 1,107Source | — | — | 41,438Source |
| Interest Expense, DebtUSD | — | 2,464Source | — | 38,557Source |
| Operating ExpensesUSD | 4,238,414Source | -141,088Source | 247,814Source | 5,428,858Source |
| Other General and Administrative ExpenseUSD | — | — | 42,673Source | — |
| Other Operating Income (Expense), NetUSD | — | — | -628,184Source | — |
| Research and Development ExpenseUSD | 92,247Source | 83,842Source | — | — |